ZNF48

Across TCGA pan-cancer cohorts, ZNF48 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of ZNF48’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ZNF48 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types ZNF48 is over-expressed in tumor, although a few such as PDAC show the opposite, repressed pattern.

HNSC, LSCC, and LUAD are the cancer types where ZNF48 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZNF48 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.712	<.001	10	view →
LSCC	All	III,IV	+1.435	<.001	9	view →
LUAD	Male	III,IV	+1.097	<.001	8	view →
CCRCC	Male	All	+0.173	<.001	7	view →
COAD	All	All	+0.513	.007	6	view →
PDAC	All	All	−0.394	.001	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

ZNF48–HNSC

Open the HNSC breakdown →